Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Comment by zadmanon Jul 25, 2017 11:50pm
119 Views
Post# 26509442

RE:RE:RE:The CFO must be kicking himself

RE:RE:RE:The CFO must be kicking himself 1.  Underestimation of the magnitude of the oil price crash.  
2.  Several untimely acquisitions as a result of point 1 that wrecked the balance sheet.  
3.  Collapse of demand for rig moving services which subsequently collapsed the pricing for services.
4.  Continued low price environment has kept a lid on pricing power ever since.    


Big list to be sure but considering the financing went a long way in the direction of fixing balance sheet issues (at the price of dilution to be certain) I ask you, what else is there really to go wrong here?  Outside of oil collapsing back to the mid 30's, I don't think much.  Every company and industry metric is up materially from the lows yet we continue to bounce along the bottom.  I chalk up the current price to truly inefficient mkt pricing.  Maybe I'm wrong but I've put my money where my mouth is.  Aug 15th will be another piece of info to tell us whether I'm right or wrong.


Zad
Bullboard Posts